Published in Yonsei Med J on September 01, 2015
Time course of Graves' orbitopathy after total thyroidectomy and radioiodine therapy for thyroid cancer. Medicine (Baltimore) (2016) 0.75
Graves' ophthalmopathy. N Engl J Med (2010) 4.24
Radioiodine therapy (RAI) for Graves' disease (GD) and the effect on ophthalmopathy: a systematic review. Clin Endocrinol (Oxf) (2008) 1.85
Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. Autoimmun Rev (2013) 1.64
A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy. J Clin Endocrinol Metab (2010) 1.37
Thyroid nodules in Graves' disease: classification, characterization, and response to treatment. Thyroid (1998) 1.37
Euthyroid and primarily hypothyroid patients develop milder and significantly more asymmetrical Graves ophthalmopathy. Br J Ophthalmol (2009) 1.28
Graves ophthalmopathy after radiation treatment of thyroid cancer. Endocr Pract (2008) 1.11
Effects of total thyroid ablation versus near-total thyroidectomy alone on mild to moderate Graves' orbitopathy treated with intravenous glucocorticoids. J Clin Endocrinol Metab (2007) 1.08
Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed graves' hyperthyroidism seen at a single center. J Clin Endocrinol Metab (2013) 1.06
The eye and thyroid disease. Curr Opin Ophthalmol (2008) 1.05
Immune mechanisms in thyroid eye disease. Thyroid (2008) 1.05
Development of severe thyroid-associated ophthalmopathy in a patient with disseminated thyroid cancer treated with recombinant human thyrotropin/radioiodine and retinoic acid. Thyroid (2005) 0.84
Extra-ocular muscle cells from patients with Graves' ophthalmopathy secrete α (CXCL10) and β (CCL2) chemokines under the influence of cytokines that are modulated by PPARγ. Autoimmun Rev (2014) 0.83
Development of Graves' disease after surgical treatment for thyroid nodules: report of four cases. Endocr J (1997) 0.82
Clinical characteristics of Graves' orbitopathy in patients showing discrepancy between levels from TBII assays and TSI bioassay. Clin Endocrinol (Oxf) (2013) 0.82
Retrospective evaluation of subtotal and total thyroidectomy in Graves' disease with and without endocrine ophthalmopathy. Eur J Endocrinol (1995) 0.81
Papillary thyroid carcinoma with thyroid-associated orbitopathy in a euthyroid state. Ophthal Plast Reconstr Surg (2007) 0.80
Graves' Disease that Developed Shortly after Surgery for Thyroid Cancer. Endocrinol Metab (Seoul) (2013) 0.80
Clinical features of thyroid-associated ophthalmopathy in clinically euthyroid Korean patients. Eye (Lond) (2012) 0.80
Correlation between TSH receptor antibody assays and clinical manifestations of Graves' orbitopathy. Yonsei Med J (2013) 0.80
Endocrine ophthalmopathy and radioiodine therapy. Acta Oncol (2006) 0.78